Caring Brands, Inc. (NASDAQ:CABR) Sees Large Increase in Short Interest

Posted by Brian Himes on Aug 26th, 2026

Caring Brands, Inc. (NASDAQ:CABR – Get Free Report) was the recipient of a large growth in short interest in August. As of August 14th, there was short interest totaling 6,138 shares, a growth of 1,337.5% from the July 30th total of 427 shares. Based on an average daily volume of 137,498 shares, the short-interest ratio is currently 0.0 days. Approximately 0.1% of the shares of the stock are short sold.

Caring Brands Stock Performance

Shares of Caring Brands stock opened at $1.33 on Wednesday. The stock’s fifty day simple moving average is $1.36 and its 200 day simple moving average is $1.14. The company has a current ratio of 4.96, a quick ratio of 4.93 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $13.84 million and a PE ratio of -1.80. Caring Brands has a 12 month low of $0.71 and a 12 month high of $5.35.

Caring Brands (NASDAQ:CABR – Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($0.10) EPS for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Caring Brands from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 11th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

Read Our Latest Stock Analysis on Caring Brands

Hedge Funds Weigh In On Caring Brands

A hedge fund recently bought a new stake in Caring Brands stock. Susquehanna International Group LLP purchased a new stake in shares of Caring Brands, Inc. (NASDAQ:CABR – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 20,771 shares of the company’s stock, valued at approximately $26,000. Susquehanna International Group LLP owned about 0.20% of Caring Brands at the end of the most recent reporting period.

About Caring Brands

(Get Free Report)

We are a wellness consumer products company. We offer several over-the-counter, or (OTC) and cosmetic, consumer products. Our method of operation is to ensure that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability. Prior to its Q3 2022 commercial launch in India as a treatment for vitiligo and psoriasis, Photocil was briefly launched in the United States markets from December 2022 until February 2023, however, was subsequently removed from the market due to insufficient sales resulting from the lack of a dedicated sales and marketing team.